Terms: = Thyroid cancer AND TAF15, hTAFII68, 8148, ENSG00000172660, TAF2N, RBP56, Npl3, Q92804 AND Diagnosis
4 results:
1. A novel fusion variant LSM14A::NR4A3 in extraskeletal myxoid chondrosarcoma.
Ngo C; Verret B; Vibert J; Cotteret S; Levy A; Pechoux CL; Haddag-Miliani L; Honore C; Faron M; Quinquis F; Cesne AL; Scoazec JY; Pierron G
Genes Chromosomes Cancer; 2023 Jan; 62(1):52-56. PubMed ID: 35932215
[TBL] [Abstract] [Full Text] [Related]
2. Extraskeletal Myxoid Chondrosarcoma with Molecularly Confirmed diagnosis: A Multicenter Retrospective Study Within the Italian Sarcoma Group.
Paioli A; Stacchiotti S; Campanacci D; Palmerini E; Frezza AM; Longhi A; Radaelli S; Donati DM; Beltrami G; Bianchi G; Barisella M; Righi A; Benini S; Fiore M; Picci P; Gronchi A
Ann Surg Oncol; 2021 Feb; 28(2):1142-1150. PubMed ID: 32572850
[TBL] [Abstract] [Full Text] [Related]
3. Extraskeletal myxoid chondrosarcoma with non-EWSR1-NR4A3 variant fusions correlate with rhabdoid phenotype and high-grade morphology.
Agaram NP; Zhang L; Sung YS; Singer S; Antonescu CR
Hum Pathol; 2014 May; 45(5):1084-91. PubMed ID: 24746215
[TBL] [Abstract] [Full Text] [Related]
4. Extraskeletal myxoid chondrosarcoma: a clinicopathologic, immunohistochemical, and molecular analysis of 18 cases.
Okamoto S; Hisaoka M; Ishida T; Imamura T; Kanda H; Shimajiri S; Hashimoto H
Hum Pathol; 2001 Oct; 32(10):1116-24. PubMed ID: 11679947
[TBL] [Abstract] [Full Text] [Related]
